Cytotoxic effect of peroxisome proliferator fenofibrate on human HepG2 hepatoma cell line and relevant mechanisms

被引:67
|
作者
Jiao, HL [1 ]
Zhao, BL [1 ]
机构
[1] Acad Sinica, Inst Biophys, Dept Mol & Cell Biol, Beijing 100101, Peoples R China
关键词
fenofibrate; peroxisome proliferator-activated receptor (PPAR); HepG2; oxidative stress; intracellular calcium; mitochondrial membrane potential (MMP);
D O I
10.1006/taap.2002.9538
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The aim of this work was to investigate the effects of hypolipidemic agent fenofibrate (FF), a peroxisome proliferator (PP), on human HepG2 cells and to characterize the intracellular events involved. The results showed that, in contrast to the tumor-promoting effects in rodents, high FF concentrations induced human HepG2 cell death through a mechanism involving an increase in the levels of reactive oxygen species (ROS) and intracellular GSH depletion, which led, through mitochondrial dysfunction and perturbation of intracellular Ca2+ homeostasis, to cell death. The nuclear receptor peroxisome proliferator-activated receptor-alpha (PPARalpha) was expressed following FF treatment. The results suggest that, although long-term administration of PPs causes liver cancer in susceptible species (e.g., rodents), FF inhibits the growth of human HepG2 cells in a dose-related manner and oxidative stress was involved in this effect. (C) 2002 Elsevier Science (USA).
引用
收藏
页码:172 / 179
页数:8
相关论文
共 50 条
  • [21] Anticancer effect of the extracts from Polyalthia evecta against human hepatoma cell line(HepG2)
    Sasipawan Machana
    Natthida Weerapreeyakul
    Sahapat Barusrux
    Asian Pacific Journal of Tropical Biomedicine, 2012, 2 (05) : 368 - 374
  • [22] STUDIES ON THE BINDING AND DEGRADATION OF HUMAN VLDL BY HUMAN HEPATOMA-CELL LINE HEPG2
    DASHTI, N
    WOLFBAUER, G
    ARTERIOSCLEROSIS, 1985, 5 (05): : A542 - A542
  • [23] Interaction of a recombinant form of apolipoprotein[a] with human fibroblasts and with the human hepatoma cell line HepG2
    Tam, SP
    Zhang, X
    Koschinsky, ML
    JOURNAL OF LIPID RESEARCH, 1996, 37 (03) : 518 - 533
  • [24] microRNA-mediated resistance to hypoglycemia in the HepG2 human hepatoma cell line
    Ueki, Satomi
    Murakami, Yuko
    Yamada, Shoji
    Kimura, Masaki
    Saito, Yoshimasa
    Saito, Hidetsugu
    BMC CANCER, 2016, 16
  • [25] Ammonia transport in murine immortalized hepatocytes and the human hepatoma cell line, HepG2
    Steele, Ian
    Handlogten, Mary
    Weiner, I. David
    GASTROENTEROLOGY, 2006, 130 (04) : A829 - A829
  • [26] microRNA-mediated resistance to hypoglycemia in the HepG2 human hepatoma cell line
    Satomi Ueki
    Yuko Murakami
    Shoji Yamada
    Masaki Kimura
    Yoshimasa Saito
    Hidetsugu Saito
    BMC Cancer, 16
  • [27] COMPLEMENT BIOSYNTHESIS BY THE HUMAN HEPATOMA-DERIVED CELL-LINE HEPG2
    MORRIS, KM
    ADEN, DP
    KNOWLES, BB
    COLTEN, HR
    JOURNAL OF CLINICAL INVESTIGATION, 1982, 70 (04): : 906 - 913
  • [28] Regulation of human β-glucoronidase by A23187 and thapsigargin in the hepatoma cell line HepG2
    Sperker, B
    Tomkiewicz, E
    Burk, O
    Barouki, R
    Kroemer, HK
    MOLECULAR PHARMACOLOGY, 2001, 59 (02) : 177 - 182
  • [29] STUDIES ON THE SULFATION OF PROTEINS FROM A HUMAN HEPATOMA-CELL LINE, HEPG2
    YU, S
    LIU, MC
    SY, J
    LIPMANN, F
    FEDERATION PROCEEDINGS, 1985, 44 (03) : 684 - 684
  • [30] Effects of HDAC inhibitors on proliferation and differentiation of the human hepatoma cell line HepG2
    Augspurger, C.
    Gross, A.
    Riester, D.
    Wegener, D.
    Schober, A.
    Gottwald, E.
    Weibezahn, K. F.
    CYTOTHERAPY, 2006, 8 : 51 - 51